- Home
- VCSA vs TURN Comparison
VCSA vs TURN Comparison
Compare VCSA & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCSA
- TURN
- Stock Information
- Founded
- VCSA 2009
- TURN 1981
- Country
- VCSA United States
- TURN United States
- Employees
- VCSA N/A
- TURN N/A
- Industry
- VCSA Computer Software: Prepackaged Software
- TURN Finance/Investors Services
- Sector
- VCSA Technology
- TURN Finance
- Exchange
- VCSA Nasdaq
- TURN Nasdaq
- Market Cap
- VCSA 38.6M
- TURN 35.4M
- IPO Year
- VCSA N/A
- TURN N/A
- Fundamental
- Price
- VCSA $3.75
- TURN $3.67
- Analyst Decision
- VCSA Buy
- TURN
- Analyst Count
- VCSA 4
- TURN 0
- Target Price
- VCSA $6.08
- TURN N/A
- AVG Volume (30 Days)
- VCSA 71.4K
- TURN 33.0K
- Earning Date
- VCSA 11-07-2024
- TURN 02-18-2025
- Dividend Yield
- VCSA N/A
- TURN N/A
- EPS Growth
- VCSA N/A
- TURN N/A
- EPS
- VCSA N/A
- TURN N/A
- Revenue
- VCSA $949,936,000.00
- TURN $129,297.00
- Revenue This Year
- VCSA N/A
- TURN N/A
- Revenue Next Year
- VCSA N/A
- TURN N/A
- P/E Ratio
- VCSA N/A
- TURN N/A
- Revenue Growth
- VCSA N/A
- TURN 6.32
- 52 Week Low
- VCSA $2.07
- TURN $3.12
- 52 Week High
- VCSA $11.70
- TURN $4.47
- Technical
- Relative Strength Index (RSI)
- VCSA 48.26
- TURN 54.15
- Support Level
- VCSA $3.27
- TURN $3.47
- Resistance Level
- VCSA $4.79
- TURN $3.80
- Average True Range (ATR)
- VCSA 0.40
- TURN 0.12
- MACD
- VCSA -0.12
- TURN -0.02
- Stochastic Oscillator
- VCSA 18.42
- TURN 42.61
About VCSA Vacasa Inc.
Vacasa Inc is a vacation rental management platform in North America, transforming the vacation rental experience by integrating purpose-built technology with expert local and national teams.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.